SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Speculating in Takeover Targets
CTG 7.7800.0%Nov 29 12:00 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: richardred who wrote (5714)12/11/2019 1:42:23 PM
From: richardred  Read Replies (1) of 6101
 
Added ENZ in quantity > 2.63. ENZ Management has made a move to create shareholder value by possibly monetizing the Therapeutics unit. The stock made a blip up late yesterday. IMO with thoughts the company might sell itself. This wasn't the case and the stock pull back today, and then some. I doubt this monetizing effort of the Therapeutics unit would have happened without Harbert Discovery Fund pushing. Given the court awards this company has previously received. IMO the unit might attract interest, or an outright bid for the whole company? If no hypothetical bid comes. I can hold till improvement comes. Either through a lucrative venture with a big partner, or new model conditions leading the way to profitability .
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext